Authors
Latest:
Glaucoma & ocular surface preservation: Key factors for ODs to considerKnow options for treatment are available
Latest:
AI and the modern optometric practice restartNew systems, digital front desks, and analytics help ODs reinvent practice management plans
Latest:
DED: Developing a 360° diagnosis and treatment planModern technology enables early detection, individualized solutions.
Latest:
Achieving improved outcomes through partnerships between optometrists and retina specialistsConsiderations in the treatment of diabetic retinopathy and diabetic macular edema.
Latest:
A practical guide to the best of the current multifocal IOLsManaging patient expectations is key to selecting the best lens
Latest:
Contact lens disinfection methods still matterLong-term success of contact lens wearers attributed to education, professional input on cleaning methods
Latest:
AAOpt 2022: Genetic testing in AMDBrad Sutton, OD, FAAO, FORS, discusses key takeaways from his discussion, "Genetic testing in AMD: critical, useful, or inappropriate," which he presented during the 2022 American Academy of Optometry meeting.
Latest:
Case report: OCT in the detection and diagnosis of neurofibromatosis type 1Neurofibromatosis type 1 (NF1) is a condition associated with significant systemic morbidity. Abnormal proliferation of cells derived from the neural crest can cause benign and malignant tumors throughout the body in NF1.
Latest:
AAOpt 2022: Helping astigmatic and presbyopic patients find comfort in their contact lensesErin Rueff, OD, PhD, FAAO, shares highlights from her 2022 American Academy of Optometry presentations in the contact lens space.
Latest:
Review Duane’s retraction syndrome diagnosis and treatmentUnderstand the condition’s structural, innervational, neurological, and genetic abnormalities
Latest:
Offer patients new contact lens technology: 4 Keys to successOne OD has polished a 4 step process of introducing new contact lens technology to patients
Latest:
Pediatric vision and digital media: A bad combinationResearch indicates that too much technology usage results in negative effects on eyesight.
Latest:
OCT, OCTA show promise in screening for DRThis imaging technique provides depth-resolved images of retinal vasculature.
Latest:
Transcript: Find out more about Allergan’s presbyopia drop NDA filingPotential presbyopia treatment coming
Latest:
Approach patients with low vision on an individual basisClinicians must think creatively for solutions to vocational rehabilitation
Latest:
AOA 2023: Providing eye care for athletesGraham Erickson, OD, FAAO, FCOVD, gives key takeaways of his presentation, "Sports vision grand rounds," which he presented during the 2023 AOA Optometry's Meeting in Washington, DC.
Latest:
OCT biomarkers associated with advanced age-related macular degenerationImaging can elucidate visual prognosis and disease progression risk.
Latest:
Allergic conjunctivitis is prevalent in youngstersSet your young patients—and their caregivers—up for success in treatment.
Latest:
IKA Keratoconus Symposium: Elevating scleral lens fittingsJamie Kuzniar, OD, discusses scleral lens fitting for patients with keratoconus at the IKA Keratoconus Symposium in Scottsdale, Arizona.
Latest:
Pearls on diagnosing and managing glaucoma for optometristsOptometrists can play an important role in early detection, earlier surgical referral to experienced skillful surgeons, surveillance, and follow-up care for glaucoma patients.
Latest:
Management of chronic allergic eye diseaseTreatment should be adjusted based on disease severity.
Latest:
Higher-order aberration correction with scleral lensesWhen considering the best modality these lenses' stability are superior.
Latest:
Navigating vision challenges in aviationOptimizing eye care for pilots is crucial for safe flying.
Latest:
My presbyopia story: How far would your patients go?Physicians share tales of creative workarounds to cope with this condition.
Latest:
NOA 2023: Bridging the gap between glaucoma news and patient careAt NOA 2023, Monique Barbour, MD, caught up with Optometry Times to tell us more about her presentation on the latest and greatest in glaucoma.
Latest:
SECO 2023: Orasis Pharmaceuticals presents pipeline update at OISPaul Smith shares an update on Orasis Pharmaceutical's CSF-1 drug and what to expect this year.
Latest:
NOA 2023: Caring for and comanaging complex cases such as squamous cell carcinoma of the conjunctivaJacobi Cleaver, OD, FAAO, caught up with Optometry Times to talk about his presentation on squamous cell carcinoma of the conjunctiva, which he discussed at the National Optometric Association in Fort Lauderdale, Florida.
